ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,292, issued on May 13, was assigned to Amgen Inc. (Thousand Oaks, Calif.) and AMGEN RESEARCH (MUNICH) GMBH (Munich).
"Antibody constructs for CDH19 and CD3" was invented by Shouhua Xiao (Foster City, Calif.), Zheng Pan (Fremont, Calif.), Dineli Wickramasinghe (San Francisco), Peter Kufer (Munich), Patrick Hoffmann (Munich), Tobias Raum (Munich), Ralf Lutterbuse (Munich), Elisabeth Nahrwold (Munich) and Claudia Blumel (Munich).
According to the abstract* released by the U.S. Patent & Trademark Office: "A bispecific antibody construct comprising a first human binding domain which binds to human CDH19 on the surface of a target cell and a second binding domain which binds to human C...